warning

Alert: Because flu cases are on the rise, children 12 and younger will be restricted from visiting hospitals and certain inpatient facilities. Learn more.

Research and Clinical Trials

Title  
Celgene ABI-007-ST-001: A phase I, open-label, multi-center, safety study of Nivolumab (BMS-936558) in combination with nab-Paclitaxel plus or minus Gemcitabine in pancreatic cancer, nab-Paclitaxel/Carboplatin in Stage IIIB/IV non-small cell lung cancer
Brief Description  
Celgene ABI-007-ST-001
Who may be Eligible  
Please contact us for eligibility criteria.
Speciality/Disorder  
Lung
Status  
OPEN
Start Date  
06/11/2015
IRB Number  
00011164
Principal Investigator  
Carrizosa, Daniel Ricardo
Contact Name  
Tesa M Adams

For More Information, Contact  Tesa  M, Adams
Phone:  980-442-2335 Fax:    
Email:  Tesa.Adams@carolinashealthcare.org
Address:1021 Morehead Medical Drive Suite 2200 Charlotte, NC 28204
Close